Advertisement

Superficial/Soft Radiation Therapy for Nonmelanoma Skin Cancer

  • Christopher M. Wolfe
  • Armand B. Cognetta
Chapter

Abstract

Similar to surgical modalities such as excision or Mohs micrographic surgery, the bulk of research forming the foundation for radiation therapy has come from retrospective analyses over the past 100 years of patients chosen for radiation therapy. Superficial radiation therapy is a viable and effective treatment option for patients over the age of 60 who are not ideal candidates for surgery. Superficial radiation therapy is curative for 90–95% of primarily treated nonaggressive basal cell and squamous cell carcinomas of the skin.

Keywords

Superficial radiation treatment Superficial radiotherapy Dermatologic radiotherapy Nonmelanoma skin cancer Basal cell carcinoma Squamous cell carcinoma 

References

  1. 1.
    Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312(7023):71–2.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Moulton BW, Pope TM. Emerging legal issues for providers in the USA. In: Elwyn G, Edwards A, Thompson R, editors. Shared decision making in health care: Achieving evidence-based patient choice. 3rd ed. Oxford: Oxford University Press; 2016. p. 38–42.CrossRefGoogle Scholar
  3. 3.
    Mulley AG. The role of shared decision making in achieving allocative efficiency in health systems. In: Elwyn G, Edwards A, Thompson R, editors. Shared decision making in health care: Achieving evidence-based patient choice. 3rd ed. Oxford: Oxford University Press; 2016. p. 30–7.CrossRefGoogle Scholar
  4. 4.
    Mulley AG, Trimble C, Elwyn G. Stop the silent misdiagnosis: patients' preferences matter. BMJ. 2012;345:e6572.CrossRefPubMedGoogle Scholar
  5. 5.
    Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, Cording E, Tomson D, Dodd C, Rollnick S, Edwards A, Barry M. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361–7.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Cognetta AB, Mendenhall WM, editors. Radiation therapy for skin Cancer. New York: Springer; 2013.Google Scholar
  7. 7.
    Goldschmidt H. Dermatologic radiotheraphy: selection of radiation qualities and treatment techniques. Int J Dermatol. 1976;15(3):171–81.CrossRefPubMedGoogle Scholar
  8. 8.
    Goldschmidt H. Radiotherapy of skin cancer: modern indications and techniques. Cutis. 1976;17(2):253–61.PubMedGoogle Scholar
  9. 9.
    Harley NH, Kolber AB, Altman SM, Gladstein AH, Buchanan S, Marx J, Grisewood E, Kopf A. Determination of half-dose depth in skin for soft x-rays. J Am Acad Dermatol. 1982;7(3):328–32.CrossRefPubMedGoogle Scholar
  10. 10.
    Jennings WA. A survey of depth dose data for X rays from 6 to 75kVp; half value layers from 0.01 to 1.0 MM AL. Br J Radiol. 1953;26(309):481–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Orton CG, Ellis F. A simplification in the use of the NSD concept in practical radiotherapy. Br J Radiol. 1973;46(547):529–37.CrossRefPubMedGoogle Scholar
  12. 12.
    Ellis F. Dose, time and fractionation: a clinical hypothesis. Clin Radiol. 1969;20(1):1–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Ellis F. Fractionation in radiotherapy. In: Deeley TJ, Wood CA, editors. Modern trends in radiotherapy, vol. 1. London: Butterworth; 1967. p. 34–51.Google Scholar
  14. 14.
    Storck H. Radiotherapy of cutaneous cancers and some other malignancies [radiotherapy of skin neoplasms with special reference to fractionated radiation]. J Dermatol Surg Oncol. 1978;4(8):573–84.CrossRefPubMedGoogle Scholar
  15. 15.
    Landthaler M, Braun-Falco O (1988) Application of TDF-factor in soft x-ray therapy. Proceedings of the 17th World Congress of Dermatology:928–930.Google Scholar
  16. 16.
    Landthaler M, Braun-Falco O. Use of the TDF factor in soft roentgen radiotherapy. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1989;40(12):774–7.PubMedGoogle Scholar
  17. 17.
    Bahmer FA. Practical use of the TDF factor in radiotherapy of basalioma and squamous cell carcinoma. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1992;43(10):625–8.PubMedGoogle Scholar
  18. 18.
    Joiner M, Bentzen S. Fractionation: the linear-quadratic approach. In: Joiner M, van der Kogel A, editors. Basic clinical radiobiology. Great Britain: Hodder Arnold; 2009. p. 102–19.CrossRefGoogle Scholar
  19. 19.
    Bentzen S, Joiner M. The linear-quadratic approach in clinical practice. In: Joiner M, van der Kogel A, editors. Basic clinical radiobiology. Great Britain: Hodder Arnold; 2009. p. 120–34.CrossRefGoogle Scholar
  20. 20.
    Cho M, Gordon L, Rembielak A, Woo TC. Utility of radiotherapy for treatment of basal cell carcinoma: a review. Br J Dermatol. 2014;171(5):968–73.CrossRefPubMedGoogle Scholar
  21. 21.
    Goldschmidt H. Treatment planning: selection of physical factors and radiation techniques. In: Goldschmidt H, Panizzon RG, editors. Modern Dermatologic Radiation Therapy. New York: Springer-Verlag; 1991.CrossRefGoogle Scholar
  22. 22.
    Mazeron JJ, Chassagne D, Crook J, Bachelot F, Brochet F, Brune D, Brunin F, Bunescu U, Daly N, Danczak S, et al. Radiation therapy of carcinomas of the skin of nose and nasal vestibule: a report of 1676 cases by the Groupe Europeen de Curietherapie. Radiother Oncol. 1988;13(3):165–73.CrossRefPubMedGoogle Scholar
  23. 23.
    Avila J, Bosch A, Aristizabal S, Frias Z, Marcial V. Carcinoma of the pinna. Cancer. 1977;40(6):2891–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Balogh K, Schwarz K. Radiotherapy of neoplasms of the external ear. Dermatologica. 1968;137(4):250–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Green R, Kopf A, Bart R. X-irradiation of basal cell epitheliomas of the eyelids and canthi. In: McCarthy WH, editor. Proceedings of the international Cancer conference. Amsterdam: VCN Blijt Publishers; 1972. p. 333–42.Google Scholar
  26. 26.
    Bart RS, Kopf AW, Petratos MA. X-ray therapy of skin cancer: evaluation of a “standardized” method for treating basal-cell epitheliomas. Proc Natl Cancer Conf. 1970;6:559–69.PubMedGoogle Scholar
  27. 27.
    Caccialanza M, Piccinno R, Percivalle S, Rozza M. Radiotherapy of carcinomas of the skin overlying the cartilage of the nose: our experience in 671 lesions. J Eur Acad Dermatol Venereol. 2009;23(9):1044–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Caccialanza M, Piccinno R, Moretti D, Rozza M. Radiotherapy of carcinomas of the skin overlying the cartilage of the nose: results in 405 lesions. Eur J Dermatol. 2003;13(5):462–5.PubMedGoogle Scholar
  29. 29.
    Caccialanza M, Piccinno R, Kolesnikova L, Gnecchi L. Radiotherapy of skin carcinomas of the pinna: a study of 115 lesions in 108 patients. Int J Dermatol. 2005;44(6):513–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Caccialanza M, Piccinno R, Grammatica A. Radiotherapy of recurrent basal and squamous cell skin carcinomas: a study of 249 re-treated carcinomas in 229 patients. Eur J Dermatol. 2001;11(1):25–8.PubMedGoogle Scholar
  31. 31.
    Caccialanza M, Piccinno R, Gaiani F, Contini D. Relevance of dermatologic radiotherapy in the therapeutic strategy of skin epithelial neoplasms: excellent results in the treatment of lesions localized on eyelids and skin overlying the cartilage of the nose. Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia. 2013;148(1):83–8.Google Scholar
  32. 32.
    Del Regato JA, Vuksanovic M. Radiotherapy of carcinomas of the skin overlying the cartilages of the nose and ear. Radiology. 1962;79:203–8.CrossRefGoogle Scholar
  33. 33.
    Cognetta AB, Howard BM, Heaton HP, Stoddard ER, Hong HG, Green WH. Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Dermatol. 2012;67(6):1235–41.CrossRefPubMedGoogle Scholar
  34. 34.
    Schulte KW, Lippold A, Auras C, Bramkamp G, Breitkopf C, Elsmann HJ, Habenicht EM, Jasnoch V, Muller-Pannes H, Rupprecht R, Suter L. Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomas. J Am Acad Dermatol. 2005;53(6):993–1001.CrossRefPubMedGoogle Scholar
  35. 35.
    Fiebelkorn HJ, Grafe E. On the therapy of tumors of the external ear. Strahlentherapie. 1960;111:525–31.PubMedGoogle Scholar
  36. 36.
    Lim JT. Irradiation of the pinna with superficial kilovoltage radiotherapy. Clin Oncol (R Coll Radiol). 1992;4(4):236–9.CrossRefGoogle Scholar
  37. 37.
    Moss T, Brand W, Battifora H. Radiation oncology. 5th ed. St. Louis: CV Mosby Co; 1979.Google Scholar
  38. 38.
    Murphy W. X-ray therapy. In: Helm F, editor. Cancer dermatology. Philadelphia: Lea & Febiger; 1979. p. 322–4.Google Scholar
  39. 39.
    Mustafa E. Ergebnisse der Nase und der Ohrmuscheln. Strahlentherapie. 1966;131:505–19.PubMedGoogle Scholar
  40. 40.
    Panizzon RG. Die Strahlentherapie des Basalioms. In: Eichmann E, Schnyder U, editors. Das Basaliom: Der haufigste Tumor der Haut. Berlin/New York: Springer; 1980. p. 103–12.Google Scholar
  41. 41.
    Parker RG, Wildermuth O. Radiation therapy of lesions overlying cartilage. I. Carcinoma of the pinna. Cancer. 1962;15:57–65.CrossRefPubMedGoogle Scholar
  42. 42.
    Storck H, Ott F, Schwartz K. Haut. Handbuch der Medizinischen Radiologie. Heidelberg: Springer; 1972.Google Scholar
  43. 43.
    Wiskemann A, Lippert H, Lotz G. Rontgentherapie der Basaliome, spinozellularen Karzinome und Keratoakanthome. In: Braun-Falco O, Marghescu S, editors. Fortschritte der Praktischen Dermatologies und Venerologie. Berlin: Springer; 1976.Google Scholar
  44. 44.
    Fitzpatrick PJ, Thompson GA, Easterbrook WM, Gallie BL, Payne DG. Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy. Int J Radiat Oncol Biol Phys. 1984;10(4):449–54.CrossRefPubMedGoogle Scholar
  45. 45.
    Fitzpatrick PJ, Jamieson DM, Thompson GA, Allt WE. Tumors of the eyelids and their treatment by radiotherapy. Radiology. 1972;104(3):661–5.CrossRefPubMedGoogle Scholar
  46. 46.
    Fitzpatrick PJ, Allt WE, Thompson GA. Cancer of the eyelids: their treatment by radiotherapy. Can Med Assoc J. 1972;106(11):1215–6. passimPubMedPubMedCentralGoogle Scholar
  47. 47.
    Gladstein AH. Efficacy, simplicity, and safety of X-ray therapy of basal-cell carcinomas on periocular skin. J Dermatol Surg Oncol. 1978;4(8):586–93.CrossRefPubMedGoogle Scholar
  48. 48.
    Petrovich Z, Parker RG, Luxton G, Kuisk H, Jepson J. Carcinoma of the lip and selected sites of head and neck skin. A clinical study of 896 patients. Radiother Oncol. 1987;8(1):11–7.CrossRefPubMedGoogle Scholar
  49. 49.
    Petrovich Z, Kuisk H, Tobochnik N, Hittle RE, Barton R, Jose L. Carcinoma of the lip. Arch Otolaryngol (Chicago, Ill: 1960). 1979;105(4):187–91.CrossRefGoogle Scholar
  50. 50.
    Petrovich Z, Kuisk H, Langholz B, Astrahan M, Luxton G, Chak L, Rice D. Treatment results and patterns of failure in 646 patients with carcinoma of the eyelids, pinna, and nose. Am J Surg. 1987;154(4):447–50.CrossRefPubMedGoogle Scholar
  51. 51.
    Szabo P. Clinical picture and roentgen therapy of lip carcinomas. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1975;26(10):524–8.PubMedGoogle Scholar
  52. 52.
    Landthaler M, Lukacs S, Braun-Falco O, Hess U. Soft radiotherapy of lip cancer. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1981;32(2):80–3.PubMedGoogle Scholar
  53. 53.
    von Essen C. Roentgen therapy of skin and lip carcinoma: factors influencing success and failure. Am J Roentgenol. 1960;83:556–70.Google Scholar
  54. 54.
    Traenkle HL, Stoll HL Jr, Lonkar A. Results of roentgen therapy of carcinoma of the lip. Arch Dermatol. 1962;85:488–9.CrossRefPubMedGoogle Scholar
  55. 55.
    Shore RE, Moseson M, Harley N, Pasternack BS. Tumors and other diseases following childhood x-ray treatment for ringworm of the scalp (Tinea capitis). Health Phys. 2003;85(4):404–8.CrossRefPubMedGoogle Scholar
  56. 56.
    Shore RE, Albert RE, Reed M, Harley N, Pasternack BS. Skin cancer incidence among children irradiated for ringworm of the scalp. Radiat Res. 1984;100(1):192–204.CrossRefPubMedGoogle Scholar
  57. 57.
    Albert RE. Carcinogenic effects of radiation on the human skin. In: Upton AC, Burns FJ, Shore RE, editors. Radiation carcinogenesis. New York: Elsevier; 1986. p. 335–45.Google Scholar
  58. 58.
    Shore RE. Radiation-induced skin cancer in humans. Med Pediatr Oncol. 2001;36(5):549–54.CrossRefPubMedGoogle Scholar
  59. 59.
    Martin H, Strong E, Spiro RH. Radiation-induced skin cancer of the head and neck. Cancer. 1970;25(1):61–71.CrossRefPubMedGoogle Scholar
  60. 60.
    Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, Stevens MM. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst. 1996;88(24):1848–53.CrossRefPubMedGoogle Scholar
  61. 61.
    Wilder RB, Kittelson JM, Shimm DS. Basal cell carcinoma treated with radiation therapy. Cancer. 1991;68(10):2134–7.CrossRefPubMedGoogle Scholar
  62. 62.
    Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989;15(3):315–28.CrossRefPubMedGoogle Scholar
  63. 63.
    Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.CrossRefPubMedGoogle Scholar
  64. 64.
    Goldschmidt H, Sherwin WK. Office radiotherapy of cutaneous carcinomas. II Indications in specific anatomic regions. J Dermatol Surg Oncol. 1983;9(1):47–76.CrossRefPubMedGoogle Scholar
  65. 65.
    Hernandez-Machin B, Borrego L, Gil-Garcia M, Hernandez BH. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol. 2007;46(5):453–9.CrossRefPubMedGoogle Scholar
  66. 66.
    Bart RS, Kopf AW, Gladstein AH. Treatment of morphea-type basal cell carcinomas with radiation therapy. Arch Dermatol. 1977;113(6):783–6.CrossRefPubMedGoogle Scholar
  67. 67.
    Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649–55.CrossRefPubMedGoogle Scholar
  68. 68.
    National Comprehensive Cancer Network NCCN Guidelines Version 1.2015 Basal Cell Skin Cancer. http://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf. Accessed 22 June 2015.
  69. 69.
    National Comprehensive Cancer Network NCCN Guidelines Version 1.2015 Squamous cell skin Cancer. http://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf. Accessed 22 June 2015.
  70. 70.
    Goldschmidt H, Breneman JC, Breneman DL. Ionizing radiation therapy in dermatology. J Am Acad Dermatol. 1994;30(2 Pt 1):157–82. quiz 183–156CrossRefPubMedGoogle Scholar
  71. 71.
    Erfurt-Berge C, Bauerschmitz J. Malignant tumours arising in chronic leg ulcers: three cases and a review of the literature. J Wound Care. 2011;20(8):396–400.CrossRefPubMedGoogle Scholar
  72. 72.
    Mendenhall WM, Amdur RJ, Hinerman RW, Cognetta AB, Mendenhall NP. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope. 2009;119(10):1994–9.CrossRefPubMedGoogle Scholar
  73. 73.
    Mendenhall WM, Parsons JT, Mendenhall NP, Million RR. T2–T4 carcinoma of the skin of the head and neck treated with radical irradiation. Int J Radiat Oncol Biol Phys. 1987;13(7):975–81.CrossRefPubMedGoogle Scholar
  74. 74.
    Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP. Subsequent neoplasms in 5-year survivors of childhood cancer: the childhood Cancer survivor study. J Natl Cancer Inst. 2010;102(14):1083–95.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Newhauser WD, Durante M. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer. 2011;11(6):438–48.CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Gatti RA. The inherited basis of human radiosensitivity. Acta Oncologica (Stockholm, Sweden). 2001;40(6):702–11.CrossRefGoogle Scholar
  77. 77.
    Kleinerman RA. Radiation-sensitive genetically susceptible pediatric sub-populations. Pediatr Radiol. 2009;39(Suppl 1):S27–31.CrossRefPubMedGoogle Scholar
  78. 78.
    Jung EG. Xeroderma pigmentosum: heterogeneous syndrome and model for UV carcinogenesis. Bull Cancer. 1978;65(3):315–21.PubMedGoogle Scholar
  79. 79.
    Gatti RA. Candidates for the molecular defect in ataxia telangiectasia. Adv Neurol. 1993;61:127–32.PubMedGoogle Scholar
  80. 80.
    Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International commission on radiological protection. Ann ICRP. 1998;28(1–2):1–157.CrossRefGoogle Scholar
  81. 81.
    Taylor AM, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Bridges BA. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 1975;258(5534):427–9.CrossRefPubMedGoogle Scholar
  82. 82.
    Alter BP. Radiosensitivity in Fanconi’s anemia patients. Radiother Oncol. 2002;62(3):345–7.CrossRefPubMedGoogle Scholar
  83. 83.
    Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998;90(8):606–11.CrossRefPubMedGoogle Scholar
  84. 84.
    Churchill-Davidson I, Johnson E. Rodent ulcers: an analysis of 711 lesions treated by radiotherapy. Br Med J. 1954;1(4877):1465–8.CrossRefPubMedPubMedCentralGoogle Scholar
  85. 85.
    Goldschmidt H, Sherwin WK. Office radiotherapy of cutaneous carcinomas. I Radiation techniques, dose schedules, and radiation protection. J Dermatol Surg Oncol. 1983;9(1):31–46.CrossRefPubMedGoogle Scholar
  86. 86.
    Shack RB. Management of radiation ulcers. South Med J. 1982;75(12):1462–6.CrossRefPubMedGoogle Scholar
  87. 87.
    Goldschmidt H, Panizzon RG, editors. Modern dermatologic radiation therapy. New York: Springer; 1991.Google Scholar
  88. 88.
    Huget-Debois H, Debois JM. Skin epithelioma of trunk and limbs. Experience with radiotherapy in 126 patients. J Belg Radiol. 1991;74(2):97–103.PubMedGoogle Scholar
  89. 89.
    Cox NH, Dyson P. Wound healing on the lower leg after radiotherapy or cryotherapy of Bowen's disease and other malignant skin lesions. Br J Dermatol. 1995;133(1):60–5.CrossRefPubMedGoogle Scholar
  90. 90.
    Dupree MT, Kiteley RA, Weismantle K, Panos R, Johnstone PA. Radiation therapy for Bowen's disease: lessons for lesions of the lower extremity. J Am Acad Dermatol. 2001;45(3):401–4.CrossRefPubMedGoogle Scholar
  91. 91.
    Wolfe CM, Cognetta AB Jr. Radiation therapy (RT) for nonmelanoma skin cancer (NMSC), a cost comparison: clarifying misconceptions. J Am Acad Dermatol. 2016;75(3):654–5.CrossRefPubMedGoogle Scholar
  92. 92.
    Shekelle PG, Ortiz E, Rhodes S, Morton SC, Eccles MP, Grimshaw JM, Woolf SH. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated? JAMA. 2001;286(12):1461–7.CrossRefPubMedGoogle Scholar
  93. 93.
    Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008;159(1):35–48.CrossRefPubMedGoogle Scholar
  94. 94.
    Motley RJ, Preston PW, Lawrence CM. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. London: British Association of Dermatologists; 2009.Google Scholar
  95. 95.
    Morton CA, Birnie AJ, Eedy DJ. British Association of Dermatologists’ guidelines for the management of squamous cell carcinoma in situ (Bowen’s disease) 2014. Br J Dermatol. 2014;170(2):245–60.CrossRefPubMedGoogle Scholar
  96. 96.
    Zloty D, Guenther LC, Sapijaszko M, Barber K, Claveau J, Adamek T, Ashkenas J. Non-melanoma skin cancer in Canada chapter 4: management of basal cell carcinoma. J Cutan Med Surg. 2015;19(3):239–48.CrossRefPubMedGoogle Scholar
  97. 97.
    Sapijaszko M, Zloty D, Bourcier M, Poulin Y, Janiszewski P, Ashkenas J. Non-melanoma skin cancer in Canada chapter 5: management of squamous cell carcinoma. J Cutan Med Surg. 2015;19(3):249–59.CrossRefPubMedGoogle Scholar
  98. 98.
    Freund L. Elements of general radio-therapy for practitioners. New York: Rebman; 1904.Google Scholar
  99. 99.
    Belot J. Radiotherapy in skin disease. New York: Rebman; 1905.CrossRefGoogle Scholar
  100. 100.
    MacKee GM. X-rays and radium in the treatment of diseases of the skin. Philadelphia: Lea & Febiger; 1921.Google Scholar
  101. 101.
    Cipollaro AC, MacKee GM, Crossland PM. X rays and radium in the treatment of diseases of the skin. Philadelphia: Lea & Febiger; 1967.Google Scholar
  102. 102.
    Panizzon RG, Cooper JS, editors. Radiation treatment and radiation reactions in dermatology. New York: Springer; 2004.Google Scholar
  103. 103.
    Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007;1:CD003412.Google Scholar
  104. 104.
    Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, Guillaume JC, Chalon R, Petit JY, Sancho-Garnier H, Prade M, Bouzy J, Chassagne D. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer. 1997;76(1):100–6.CrossRefPubMedPubMedCentralGoogle Scholar
  105. 105.
    Hall VL, Leppard BJ, McGill J, Kesseler ME, White JE, Goodwin P. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol. 1986;37(1):33–4.CrossRefPubMedGoogle Scholar
  106. 106.
    Goldschmidt H. Dermatologic radiotherapy 1981. Arch Dermatol. 1981;117(11):685–8.CrossRefPubMedGoogle Scholar
  107. 107.
    Silverman MK, Kopf AW, Gladstein AH, Bart RS, Grin CM, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol. 1992;18(7):549–54.CrossRefPubMedGoogle Scholar
  108. 108.
    Stoll HL Jr, Milgrom H, Traenkle HL. Results of roentgen therapy of carcinoma of the nose. Arch Dermatol. 1964;90:577–80.CrossRefPubMedGoogle Scholar
  109. 109.
    Rubisz-Brzezinska J, Musialowicz D, Zebracka T. Treatment of basal cell epitheliomas. Dermatol Digest. 1976;(9):10–5.Google Scholar
  110. 110.
    Fischbach AJ, Sause WT, Plenk HP. Radiation therapy for skin cancer. West J Med. 1980;133(5):379–82.PubMedPubMedCentralGoogle Scholar
  111. 111.
    Robins P, Bennett R. Current concepts in the management of skin cancer. New York: CLINICOM; 1979.Google Scholar
  112. 112.
    Chahbazian CM, Brown GS. Radiation therapy for carcinoma of the skin of the face and neck. Special considerations. JAMA. 1980;244(10):1135–7.CrossRefPubMedGoogle Scholar
  113. 113.
    Lederman M. Radiation treatment of cancer of the eyelids. Br J Ophthalmol. 1976;60(12):794–805.CrossRefPubMedPubMedCentralGoogle Scholar
  114. 114.
    Del Regato J, Spjut H. Ackerman and Del Regato’s Cancer: diagnosis, treatment, and prognosis. St. Louis: CV Mosby Co; 1977.Google Scholar
  115. 115.
    Renfer H. Treatment of skin tumors in the medial canthus with a special reference to the function of the lacrimal ducts. Strahlentherapie. 1956;99(3):345–53.PubMedGoogle Scholar
  116. 116.
    Ehring F, Gattwinkel U. Radiotherapy of upper lip basalioma. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1974;25(8):368–72.PubMedGoogle Scholar
  117. 117.
    Szabo P. Clinical picture and radiotherapy of scalp carcinomas. Zeitschrift fur Hautkrankheiten. 1978;53(13):449–52.PubMedGoogle Scholar
  118. 118.
    Hliniak A, Maciejewski B, Trott KR. The influence of the number of fractions, overall treatment time and field size on the local control of cancer of the skin. Br J Radiol. 1983;56(668):596–8.CrossRefPubMedGoogle Scholar
  119. 119.
    Caccialanza M, Piccinno R, Beretta M, Gnecchi L. Results and side effects of dermatologic radiotherapy: a retrospective study of irradiated cutaneous epithelial neoplasms. J Am Acad Dermatol. 1999;41(4):589–94.PubMedGoogle Scholar
  120. 120.
    Locke J, Karimpour S, Young G, Lockett MA, Perez CA. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):748–55.CrossRefPubMedGoogle Scholar
  121. 121.
    Veness MJ, Harris D. Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. Australas Radiol. 2007;51(1):12–20.CrossRefPubMedGoogle Scholar
  122. 122.
    Morozov AI, Barkanov AI, Melenchuk IP, Lukhanina IV, Korshakova RG. Treatment of skin cancer (based on data from Moscow region cancer institutes). Vopr Onkol. 1976;22(8):66–70.PubMedGoogle Scholar
  123. 123.
    Ashby MA, Smith J, Ainslie J, McEwan L. Treatment of nonmelanoma skin cancer at a large Australian center. Cancer. 1989;63(9):1863–71.CrossRefPubMedGoogle Scholar
  124. 124.
    Silva JJ, Tsang RW, Panzarella T, Levin W, Wells W. Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret hospital experience, 1982–1993. Int J Radiat Oncol Biol Phys. 2000;47(2):451–9.CrossRefPubMedGoogle Scholar
  125. 125.
    Wilder RB, Shimm DS, Kittelson JM, Rogoff EE, Cassady JR. Recurrent basal cell carcinoma treated with radiation therapy. Arch Dermatol. 1991;127(11):1668–72.CrossRefPubMedGoogle Scholar
  126. 126.
    Chan S, Dhadda AS, Swindell R. Single fraction radiotherapy for small superficial carcinoma of the skin. Clin Oncol (R Coll Radiol). 2007;19(4):256–9.CrossRefGoogle Scholar
  127. 127.
    Tsao MN, Tsang RW, Liu FF, Panzarella T, Rotstein L. Radiotherapy management for squamous cell carcinoma of the nasal skin: the Princess Margaret hospital experience. Int J Radiat Oncol Biol Phys. 2002;52(4):973–9.CrossRefPubMedGoogle Scholar
  128. 128.
    Lukas VanderSpek LA, Pond GR, Wells W, Tsang RW. Radiation therapy for Bowen’s disease of the skin. Int J Radiat Oncol Biol Phys. 2005;63(2):505–10.CrossRefPubMedGoogle Scholar
  129. 129.
    Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276(8):637–9.CrossRefPubMedGoogle Scholar
  130. 130.
    Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol. 1999;135(10):1177–83.CrossRefPubMedGoogle Scholar
  131. 131.
    Pampena R, Palmieri T, Kyrgidis A, Ramundo D, Iotti C, Lallas A, Moscarella E, Borsari S, Argenziano G, Longo C. Orthovoltage radiotherapy for nonmelanoma skin cancer (NMSC): comparison between 2 different schedules. J Am Acad Dermatol. 2016;74(2):341–7.CrossRefPubMedGoogle Scholar
  132. 132.
    von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573–7.CrossRefGoogle Scholar
  133. 133.
    Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18(6):805–35.CrossRefPubMedGoogle Scholar
  134. 134.
    Nijsten T, Spuls P, Stern RS. STROBE: a Beacon for observational studies. Arch Dermatol. 2008;144(9):1200–4.CrossRefPubMedGoogle Scholar
  135. 135.
    Dekkers OM, Egger M, Altman DG, Vandenbroucke JP. Distinguishing case series from cohort studies. Ann Intern Med. 2012;156(1 Pt 1):37–40.CrossRefPubMedGoogle Scholar
  136. 136.
    Esene IN, Ngu J, El Zoghby M, Solaroglu I, Sikod AM, Kotb A, Dechambenoit G, El Husseiny H. Case series and descriptive cohort studies in neurosurgery: the confusion and solution. Childs Nerv Syst. 2014;30(8):1321–32.CrossRefPubMedGoogle Scholar
  137. 137.
    Fletcher RH, Fletcher SW. Clinical epidemiology: the essentials. 5th ed. Baltimore: Lippincott Williams & Wilkins; 2014.Google Scholar
  138. 138.
    Hennekens CH, Buring JE. Epidemiology in medicine. 1st ed. Philadelphia: Lippincott Williams & Wilkins; 1987.Google Scholar
  139. 139.
    Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.Google Scholar
  140. 140.
    Szklo M, Nieto FJ. Epidemiology: beyond the basics. 3rd ed. Burlington: Jones & Bartlett Learning; 2014.Google Scholar
  141. 141.
    Garton H, Barker FG, Haine SJ. Neurosurgical epidemiology and outcomes assessment. In: Winn RH, editor. Youmans neurological surgery, vol. 1. Philadelphia: Elsevier; 2011. p. 183–202.CrossRefGoogle Scholar
  142. 142.
    Krema H, Herrmann E, Albert-Green A, Payne D, Laperriere N, Chung C. Orthovoltage radiotherapy in the management of medial canthal basal cell carcinoma. Br J Ophthalmol. 2013;97(6):730–4.CrossRefPubMedGoogle Scholar
  143. 143.
    Seegenschmiedt MH, Oberste-Beulmann S, Lang E, Lang B, Guntrum F, Olschewski T. Radiotherapy for basal cell carcinoma Local control and cosmetic outcome. Strahlenther Onkol. 2001;177(5):240–6.CrossRefPubMedGoogle Scholar
  144. 144.
    Duinkerken CW, Lohuis PJ, Heemsbergen WD, Zupan-Kajcovski B, Navran A, Hamming-Vrieze O, Klop WM, Balm FJ, Al-Mamgani A. Orthovoltage for basal cell carcinoma of the head and neck: excellent local control and low toxicity profile. Laryngoscope. 2016;126(8):1796–802.CrossRefPubMedGoogle Scholar
  145. 145.
    Caccialanza M, Piccinno R, Cuka E, Alberti Violetti S, Rozza M. Radiotherapy of morphea-type basal cell carcinoma: results in 127 cases. J Eur Acad Dermatol Venereol. 2014;28(12):1751–5.CrossRefPubMedGoogle Scholar
  146. 146.
    Rodriguez JM, Deutsch GP. The treatment of periocular basal cell carcinomas by radiotherapy. Br J Ophthalmol. 1992;76(4):195–7.CrossRefPubMedPubMedCentralGoogle Scholar
  147. 147.
    Zagrodnik B, Kempf W, Seifert B, Muller B, Burg G, Urosevic M, Dummer R. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer. 2003;98(12):2708–14.CrossRefPubMedGoogle Scholar
  148. 148.
    Barysch MJ, Eggmann N, Beyeler M, Panizzon RG, Seifert B, Dummer R. Long-term recurrence rate of large and difficult to treat cutaneous squamous cell carcinomas after superficial radiotherapy. Dermatology. 2012;224(1):59–65.CrossRefPubMedGoogle Scholar
  149. 149.
    Lovett RD, Perez CA, Shapiro SJ, Garcia DM. External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys. 1990;19(2):235–42.CrossRefPubMedGoogle Scholar
  150. 150.
    Mosekilde E. Results of treatment of skin cancer with ultrasoft roentgen rays given in a single dose. Acta Radiol. 1951;36(1):28–34.CrossRefPubMedGoogle Scholar
  151. 151.
    Schlienger P, Brunin F, Desjardins L, Laurent M, Haye C, Vilcoq JR. External radiotherapy for carcinoma of the eyelid: report of 850 cases treated. Int J Radiat Oncol Biol Phys. 1996;34(2):277–87.CrossRefPubMedGoogle Scholar
  152. 152.
    Abbatucci JS, Boulier N, Laforge T, Lozier JC. Radiation therapy of skin carcinomas: results of a hypofractionated irradiation schedule in 675 cases followed more than 2 years. Radiother Oncol. 1989;14(2):113–9.CrossRefPubMedGoogle Scholar
  153. 153.
    Griep C, Davelaar J, Scholten AN, Chin A, Leer JW. Electron beam therapy is not inferior to superficial x-ray therapy in the treatment of skin carcinoma. Int J Radiat Oncol Biol Phys. 1995;32(5):1347–50.CrossRefPubMedGoogle Scholar
  154. 154.
    Nordman EM, Nordman LE. Treatment of basal cell carcinoma of the eyelid. Acta Ophthalmol. 1978;56(3):349–56.CrossRefGoogle Scholar
  155. 155.
    Biro L, Price E, MacWilliams P. Basal-cell carcinoma in office practice. N Y State J Med. 1975;75(9):1427–33.PubMedGoogle Scholar
  156. 156.
    Nevrkla E, Newton KA. A survey of the treatment of 200 cases of basal cell carcinoma (1959–1966 inclusive). Br J Dermatol. 1974;91(4):429–33.CrossRefPubMedGoogle Scholar
  157. 157.
    Cobb GM, Thompson GA, Allt WE. Treatment of basal cell carcinoma of the eyelids by radiotherapy. Can Med Assoc J. 1964;91:743–8.PubMedPubMedCentralGoogle Scholar
  158. 158.
    Ebbehoj E. Experiences in the treatment of skin cancer with ultrasoft roentgen rays, 1933–1936. Acta Radiol. 1951;36(1):17–27.CrossRefPubMedGoogle Scholar
  159. 159.
    Jensen TS, Vetner MO. Treatment of 443 cases of skin carcinoma with curettage and soft roentgen rays by the Ebbehoj method. Acta Radiol Ther Phys Biol. 1973;12(5):369–77.CrossRefPubMedGoogle Scholar
  160. 160.
    Eberhard TP. Treatment of epitheliomas of the skin. Radiology. 1947;49(5):620–6.CrossRefPubMedGoogle Scholar
  161. 161.
    Reymann F, Kopp H. Treatment of basal cell carcinoma of the skin with ultrasoft X-rays. Dermatologica. 1978;156(1):40–7.CrossRefPubMedGoogle Scholar
  162. 162.
    Kopf AW. Computer analysis of 3531 basal-cell carcinomas of the skin. J Dermatol. 1979;6(5):267–81.CrossRefPubMedGoogle Scholar
  163. 163.
    Orton CI. The treatment of basal cell carcinoma by radiotherapy. Clin Oncol. 1978;4(4):317–22.PubMedGoogle Scholar
  164. 164.
    Finizio L, Vidali C, Calacione R, Beorchia A, Trevisan G. What is the current role of radiation therapy in the treatment of skin carcinomas? Tumori. 2002;88(1):48–52.PubMedGoogle Scholar
  165. 165.
    Epstein E. Thyroid cancer due to x-ray treatment of acne. JAMA. 1969;209(10):1529–30.  https://doi.org/10.1001/jama.1969.03160230063025.CrossRefPubMedGoogle Scholar
  166. 166.
    Shore RE, Moseson M, Xue X, Tse Y, Harley N, Pasternack BS. Skin cancer after X-ray treatment for scalp ringworm. Radiat Res. 2002;157(4):410–8.CrossRefPubMedGoogle Scholar
  167. 167.
    Lindelof B, Eklund G. Incidence of malignant skin tumors in 14,140 patients after grenz-ray treatment for benign skin disorders. Arch Dermatol. 1986;122(12):1391–5.CrossRefPubMedGoogle Scholar
  168. 168.
    Landthaler M, Hagspiel HJ, Braun-Falco O. Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors. Arch Dermatol. 1995;131(2):182–6.CrossRefPubMedGoogle Scholar
  169. 169.
    Caccialanza M, Cuka E, Piccinno R, Rozza M. Risk of radiation-induced skin neoplasms after radiotherapy for cutaneous malignant tumors: a study on 5875 patients. G Ital Dermatol Venereol. 2015;150(4):488–9.PubMedGoogle Scholar
  170. 170.
    Halpern JN. Radiation therapy in skin cancer. A historical perspective and current applications. Dermatol Surg. 1997;23(11):1089–93.CrossRefPubMedGoogle Scholar
  171. 171.
    Rogers HW, Coldiron BM. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol. 2009;61(1):96–103.CrossRefPubMedGoogle Scholar
  172. 172.
    Kauvar AN, Cronin T Jr, Roenigk R, Hruza G, Bennett R. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods. Dermatol surgery. 2015;41(5):550–71.CrossRefGoogle Scholar
  173. 173.
    Cook J, Zitelli JA. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol. 1998;39(5 Pt 1):698–703.CrossRefPubMedGoogle Scholar
  174. 174.
    Chhabra KR, Sacks GD, Dimick JB. Surgical decision making: challenging dogma and incorporating patient preferences. JAMA. 2017;317(4):357–8.  https://doi.org/10.1001/jama.2016.18719.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Christopher M. Wolfe
    • 1
  • Armand B. Cognetta
    • 1
  1. 1.Division of Dermatology, Department of Clinical SciencesMohs Micrographic Surgery, Florida State University College of MedicineTallahasseeUSA

Personalised recommendations